UBS Group
LFMD icon

UBS Group’s LifeMD LFMD Stock Holding History

UBS Group’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$866K Sell
209,643
-72,452
-26% -$320K ﹤0.01% 5849
2026
Q1 		$1.02M Sell
282,095
-391,913
-58% -$1.36M ﹤0.01% 5544
2025
Q4 		$2.3M Sell
674,008
-189,014
-22% -$917K ﹤0.01% 4844
2025
Q3 		$5.86M Sell
863,022
-74,309
-8% -$614K ﹤0.01% 3874
2025
Q2 		$12.8M Buy
937,331
+859,444
+1,103% +$8.12M ﹤0.01% 2834
2025
Q1 		$424K Sell
77,887
-167,021
-68% -$948K ﹤0.01% 5982
2024
Q4 		$1.21M Buy
244,908
+86,785
+55% +$455K ﹤0.01% 5156
2024
Q3 		$829K Buy
158,123
+21,654
+16% +$125K ﹤0.01% 4816
2024
Q2 		$936K Buy
136,469
+136,306
+83,623% +$1.25M ﹤0.01% 4475
2024
Q1 		$1.68K Buy
+163
New +$1.21K ﹤0.01% 8083
2023
Q3 		– Sell
-975
Closed -$4.24K – 9742
2023
Q2 		$4.24K Buy
+975
New +$2.17K ﹤0.01% 7554
2023
Q1 		– Sell
-7,322
Closed -$14.2K – 10011
2022
Q4 		$14.2K Buy
+7,322
New +$16.4K ﹤0.01% 8099
2022
Q3 		– Sell
-2,295
Closed -$5K – 10657
2022
Q2 		$5K Sell
2,295
-2,322
-50% -$5.77K ﹤0.01% 8898
2022
Q1 		$16K Buy
4,617
+4,601
+28,756% +$16.3K ﹤0.01% 7740
2021
Q4 		$0 Sell
16
-1
-6% -$5 ﹤0.01% 10494
2021
Q3 		$0 Buy
+17
New +$145 ﹤0.01% 9826
2021
Q2 		– Sell
-3,631
Closed -$57K – 9614
2021
Q1 		$57K Buy
+3,631
New +$65.4K ﹤0.01% 6414

Other funds holding LFMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group's LFMD Position: Q2 2026 in Review

UBS Group reduced its LifeMD (LFMD) stake by 26% in Q2 2026, selling an estimated $320K and leaving 209,643 shares worth $866K. The position accounts for ﹤0.01% of the portfolio, ranked #5849.

UBS Group first reported a position in LFMD in Q1 2021 and has held it in 17 quarters since. The position peaked at $12.8M in Q2 2025. 115 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • UBS Group held 209,643 shares of LifeMD worth $866K as of Q2 2026.
  • UBS Group sold 72,452 LifeMD shares in Q2 2026, an estimated $320K.
  • LifeMD made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5849 holding.
  • UBS Group first reported a position in LifeMD in Q1 2021 and has held it in 17 quarters since.
  • UBS Group's LifeMD position peaked at $12.8M in Q2 2025.
  • 115 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.